Leukotriene Receptor Antagonist [EPC]

Leukotriene Receptor Antagonist [EPC] was reported 29263 times

These side effects are most commonly reported by patients taking drugs of the Leukotriene Receptor Antagonist [EPC] class:

# Drug class Count
0 ASTHMA 3518
1 DYSPNOEA 3295
2 HEADACHE 2341
3 DRUG INEFFECTIVE 2277
4 FATIGUE 2269
5 COUGH 2188
6 PAIN 1729
7 NAUSEA 1713
8 WHEEZING 1697
9 PNEUMONIA 1638
10 OFF LABEL USE 1391
11 DIARRHOEA 1357
12 MALAISE 1280
13 RASH 1261
14 ANXIETY 1211
15 PRURITUS 1208
16 DIZZINESS 1201
17 PRODUCT DOSE OMISSION ISSUE 1162
18 PYREXIA 1132
19 VOMITING 1104
20 HYPERTENSION 1075
21 ARTHRALGIA 925
22 HYPERSENSITIVITY 916
23 PRODUCT USE IN UNAPPROVED INDICATION 858
24 DRUG HYPERSENSITIVITY 855
25 CONDITION AGGRAVATED 854
26 UPPER RESPIRATORY TRACT INFECTION 848
27 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 845
28 SINUSITIS 843
29 FALL 804
30 NASOPHARYNGITIS 800
31 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 797
32 COVID-19 794
33 INSOMNIA 793
34 ASTHENIA 783
35 PAIN IN EXTREMITY 781
36 GASTROOESOPHAGEAL REFLUX DISEASE 764
37 DEPRESSION 758
38 PRODUCTIVE COUGH 745
39 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 744
40 CHEST DISCOMFORT 743
41 WEIGHT DECREASED 742
42 PRODUCT USE ISSUE 740
43 INJECTION SITE PAIN 732
44 BACK PAIN 716
45 CONSTIPATION 703
46 URTICARIA 689
47 INFECTION 667
48 DEATH 635
49 WEIGHT INCREASED 609
50 ERYTHEMA 608
51 HYPERHIDROSIS 593
52 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 593
53 INFLUENZA 593
54 CHEST PAIN 588
55 ILLNESS 587
56 BRONCHITIS 556
57 OBSTRUCTIVE AIRWAYS DISORDER 525
58 FEELING ABNORMAL 520
59 URINARY TRACT INFECTION 510
60 FULL BLOOD COUNT ABNORMAL 500
61 NASAL CONGESTION 489
62 JOINT SWELLING 481
63 SOMNOLENCE 479
64 RHEUMATOID ARTHRITIS 465
65 BLOOD PRESSURE INCREASED 462
66 SLEEP APNOEA SYNDROME 459
67 EXPOSURE DURING PREGNANCY 457
68 PERIPHERAL SWELLING 450
69 MUSCLE SPASMS 448
70 DRUG INTOLERANCE 446
71 CARDIAC DISORDER 443
72 FLUID RETENTION 442
73 ABDOMINAL PAIN UPPER 441
74 HEPATIC ENZYME INCREASED 441
75 SLEEP DISORDER 439
76 OROPHARYNGEAL PAIN 426
77 RASH ERYTHEMATOUS 426
78 DECREASED APPETITE 424
79 INFUSION RELATED REACTION 420
80 OVERDOSE 413
81 FOOD ALLERGY 412
82 GAIT DISTURBANCE 409
83 HOSPITALISATION 407
84 ABDOMINAL DISCOMFORT 406
85 HYPOTHYROIDISM 403
86 INTENTIONAL PRODUCT MISUSE 403
87 ABDOMINAL PAIN 402
88 TREMOR 399
89 SEASONAL ALLERGY 390
90 DYSPNOEA EXERTIONAL 388
91 BURNING SENSATION 386
92 IMMUNODEFICIENCY 380
93 PSORIASIS 376
94 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 371
95 DRY SKIN 371
96 MIGRAINE 371
97 RHINORRHOEA 364
98 OEDEMA PERIPHERAL 361
99 THROMBOCYTOPENIA 361
100 OEDEMA 359
101 RESPIRATORY TRACT INFECTION 356
102 NIGHTMARE 350
103 SUICIDAL IDEATION 346
104 OXYGEN SATURATION DECREASED 345
105 HYPOTENSION 340
106 HYPOAESTHESIA 339
107 PARAESTHESIA 336
108 PRESCRIBED OVERDOSE 331
109 RHINITIS ALLERGIC 331
110 BLOOD TEST ABNORMAL 330
111 LUNG DISORDER 330
112 VISION BLURRED 328
113 AGGRESSION 322
114 MYALGIA 322
115 HEART RATE INCREASED 321
116 EYE PAIN 316
117 LOWER RESPIRATORY TRACT INFECTION 307
118 FIBROMYALGIA 304
119 ECZEMA 303
120 MEMORY IMPAIRMENT 298
121 RENAL DISORDER 297
122 DYSPHONIA 293
123 CARPAL TUNNEL SYNDROME 292
124 PALPITATIONS 292
125 TREATMENT FAILURE 292
126 DEPRESSED MOOD 281
127 ALOPECIA 279
128 CONTUSION 279
129 DERMATITIS ATOPIC 275
130 CHILLS 273
131 CONFUSIONAL STATE 272
132 CONTRAINDICATED PRODUCT ADMINISTERED 271
133 HYPOXIA 271
134 TEMPERATURE REGULATION DISORDER 268
135 STRESS 266
136 INCORRECT DOSE ADMINISTERED 262
137 SWELLING 262
138 ATRIAL FIBRILLATION 259
139 FOETAL DEATH 254
140 DRUG INTERACTION 253
141 THROMBOSIS 252
142 COELIAC DISEASE 251
143 INJECTION SITE ERYTHEMA 251
144 BURSITIS 250
145 ANAEMIA 248
146 PULMONARY EMBOLISM 248
147 SENSITISATION 246
148 MUSCULAR WEAKNESS 242
149 POLYCYSTIC OVARIES 241
150 DEHYDRATION 240
151 SKIN EXFOLIATION 238
152 ABDOMINAL DISTENSION 237
153 DYSPEPSIA 232
154 MIDDLE INSOMNIA 229
155 SPUTUM DISCOLOURED 228
156 HAEMOPTYSIS 225
157 EOSINOPHILIA 222
158 GASTROINTESTINAL DISORDER 222
159 DISCOMFORT 221
160 FLUSHING 220
161 THERAPEUTIC RESPONSE DECREASED 220
162 AGITATION 218
163 ANGER 218
164 HALLUCINATION 216
165 LOSS OF CONSCIOUSNESS 216
166 ANAPHYLACTIC REACTION 214
167 INTENTIONAL PRODUCT USE ISSUE 213
168 ACUTE KIDNEY INJURY 212
169 NEUROPATHY PERIPHERAL 212
170 ADVERSE DRUG REACTION 209
171 EPISTAXIS 208
172 PULMONARY FIBROSIS 203
173 DRY EYE 202
174 RESPIRATORY TRACT CONGESTION 200
175 EAR INFECTION 199
176 MUSCULOSKELETAL STIFFNESS 197
177 ARTHRITIS 196
178 THROAT IRRITATION 195
179 BLOOD PRESSURE DECREASED 192
180 CHRONIC KIDNEY DISEASE 192
181 EJECTION FRACTION 191
182 OSTEOPOROSIS 191
183 IRRITABILITY 190
184 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 190
185 TACHYCARDIA 189
186 ABNORMAL BEHAVIOUR 188
187 BALANCE DISORDER 188
188 DYSPHAGIA 187
189 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 187
190 VISUAL IMPAIRMENT 187
191 INJECTION SITE SWELLING 184
192 DRY MOUTH 182
193 INJECTION SITE BRUISING 182
194 CARDIAC FAILURE CONGESTIVE 181
195 INFUSION SITE PAIN 181
196 EYE PRURITUS 179
197 HOT FLUSH 179
198 RESPIRATORY SYMPTOM 178
199 SINUS DISORDER 178
200 CATARACT 177
201 INJECTION SITE PRURITUS 177
202 VERTIGO 176
203 MULTIPLE ALLERGIES 175
204 WHITE BLOOD CELL COUNT DECREASED 174
205 HERPES ZOSTER 173
206 EYE IRRITATION 172
207 INFLUENZA LIKE ILLNESS 171
208 SURGERY 171
209 IMPAIRED QUALITY OF LIFE 170
210 ANGIOEDEMA 169
211 MATERNAL EXPOSURE DURING PREGNANCY 169
212 RENAL FAILURE 168
213 PLATELET COUNT DECREASED 167
214 RESPIRATORY FAILURE 167
215 ADVERSE EVENT 166
216 BLOOD GLUCOSE INCREASED 165
217 SLEEP TERROR 164
218 OCULAR HYPERAEMIA 162
219 FUNGAL INFECTION 160
220 SEPSIS 160
221 CEREBROVASCULAR ACCIDENT 159
222 NECK PAIN 159
223 VIRAL INFECTION 159
224 SEIZURE 157
225 MOOD ALTERED 156
226 SNEEZING 156
227 INFUSION SITE ERYTHEMA 154
228 CELLULITIS 153
229 TYPE 2 DIABETES MELLITUS 153
230 ACCIDENTAL EXPOSURE TO PRODUCT 149
231 EMOTIONAL DISTRESS 149
232 PRODUCT QUALITY ISSUE 149
233 RHINITIS 148
234 CRYING 147
235 CARDIAC FAILURE 146
236 NO ADVERSE EVENT 146
237 FEELING HOT 145
238 PANIC ATTACK 145
239 AMNESIA 144
240 SWELLING FACE 144
241 THERAPY INTERRUPTED 144
242 VASCULITIS 144
243 BRONCHIECTASIS 143
244 GENERAL PHYSICAL HEALTH DETERIORATION 142
245 CHRONIC SINUSITIS 141
246 SYNCOPE 140
247 RALES 138
248 RESPIRATORY DISORDER 137
249 UPPER-AIRWAY COUGH SYNDROME 134
250 BLOOD COUNT ABNORMAL 133
251 DIABETES MELLITUS 133
252 RASH PRURITIC 133
253 THERAPEUTIC RESPONSE SHORTENED 133
254 DISTURBANCE IN ATTENTION 132
255 OSTEOARTHRITIS 131
256 BONE PAIN 130
257 PRODUCT DOSE OMISSION IN ERROR 129
258 BREATH SOUNDS ABNORMAL 128
259 FORCED EXPIRATORY VOLUME DECREASED 127
260 HYPERGLYCAEMIA 125
261 NERVOUSNESS 125
262 PLEURAL EFFUSION 125
263 UNEVALUABLE EVENT 125
264 EXPOSURE VIA SKIN CONTACT 124
265 ABNORMAL DREAMS 123
266 MOOD SWINGS 123
267 INSURANCE ISSUE 122
268 PULMONARY VASCULITIS 122
269 BLISTER 121
270 LETHARGY 121
271 HAEMOGLOBIN DECREASED 119
272 NASAL POLYPS 119
273 PULMONARY ALVEOLAR HAEMORRHAGE 119
274 FLATULENCE 118
275 HYPOACUSIS 118
276 INTENTIONAL DOSE OMISSION 118
277 MOBILITY DECREASED 118
278 MENTAL DISORDER 117
279 PULMONARY MASS 116
280 EOSINOPHIL COUNT INCREASED 115
281 EYE SWELLING 115
282 LACRIMATION INCREASED 115
283 NEPHROLITHIASIS 114
284 GOUT 113
285 HAEMORRHAGE 113
286 NEUROLOGICAL SYMPTOM 113
287 RETCHING 110
288 PULMONARY FUNCTION TEST ABNORMAL 109
289 STOMATITIS 109
290 ARTERIOSCLEROSIS CORONARY ARTERY 108
291 ILL-DEFINED DISORDER 108
292 NEURITIS 108
293 SKIN DISCOLOURATION 107
294 SECRETION DISCHARGE 106
295 THERAPEUTIC RESPONSE UNEXPECTED 106
296 PRODUCT SUBSTITUTION ISSUE 105
297 BLOOD CREATININE INCREASED 104
298 CYSTITIS 104
299 DISEASE RECURRENCE 104
300 LIMB INJURY 103
301 NASAL OEDEMA 102
302 NODULE 102
303 POOR QUALITY SLEEP 102
304 THERAPY NON-RESPONDER 102
305 TINNITUS 102
306 INFUSION SITE SWELLING 101
307 CONJUNCTIVITIS ALLERGIC 100
308 DUST ALLERGY 100
309 SPIROMETRY ABNORMAL 100
310 PSYCHOMOTOR HYPERACTIVITY 99
311 RASH MACULAR 99
312 ARTERIOSCLEROSIS 98
313 CANDIDA INFECTION 98
314 GASTROINTESTINAL HAEMORRHAGE 98
315 HYPONATRAEMIA 98
316 MYOCARDIAL INFARCTION 98
317 OBSTRUCTION 97
318 BLOOD PRESSURE SYSTOLIC INCREASED 96
319 DEEP VEIN THROMBOSIS 96
320 EMPHYSEMA 96
321 GASTROENTERITIS VIRAL 96
322 INJECTION SITE REACTION 96
323 BRONCHOSPASM 95
324 DERMATITIS CONTACT 95
325 PRODUCT ADMINISTRATION INTERRUPTED 95
326 STAPHYLOCOCCAL INFECTION 95
327 DRUG DOSE OMISSION 94
328 SINUS CONGESTION 94
329 WHITE BLOOD CELL COUNT INCREASED 94
330 BACTERIAL INFECTION 93
331 MITE ALLERGY 93
332 BLOOD POTASSIUM DECREASED 92
333 CHOLELITHIASIS 91
334 HIATUS HERNIA 91
335 INFLAMMATION 91
336 OCULAR DISCOMFORT 91
337 NEURALGIA 90
338 PHOTOPHOBIA 90
339 ROAD TRAFFIC ACCIDENT 90
340 INJURY 89
341 BLOOD IMMUNOGLOBULIN E INCREASED 88
342 MEDICATION ERROR 88
343 ASTHMATIC CRISIS 87
344 BLOOD CHOLESTEROL INCREASED 87
345 DYSGEUSIA 87
346 INTERVERTEBRAL DISC DEGENERATION 87
347 MYCOTIC ALLERGY 87
348 RESPIRATORY SYNCYTIAL VIRUS INFECTION 87
349 EAR PAIN 86
350 SKIN LESION 86
351 SUICIDE ATTEMPT 86
352 INJECTION SITE RASH 85
353 NEUTROPENIA 85
354 SKIN FISSURES 85
355 DIASTOLIC DYSFUNCTION 84
356 NORMOCHROMIC NORMOCYTIC ANAEMIA 84
357 TRANSIENT ISCHAEMIC ATTACK 84
358 ARTHROPATHY 83
359 INFUSION SITE DISCHARGE 83
360 OBSTRUCTIVE SLEEP APNOEA SYNDROME 83
361 THROAT TIGHTNESS 83
362 DISEASE PROGRESSION 82
363 HEAD INJURY 82
364 LIP SWELLING 82
365 NIGHT SWEATS 82
366 DEVICE ISSUE 81
367 HYPERSOMNIA 81
368 OBESITY 81
369 APHONIA 80
370 DIVERTICULITIS 80
371 HEART RATE DECREASED 80
372 PARANOIA 80
373 PRODUCT DOSE OMISSION 80
374 INJECTION SITE URTICARIA 79
375 JOINT INJURY 79
376 PANCREATITIS 79
377 RENAL IMPAIRMENT 79
378 CHOKING 78
379 CONJUNCTIVITIS 78
380 EJECTION FRACTION ABNORMAL 78
381 INFUSION SITE HAEMORRHAGE 78
382 INJECTION SITE HAEMORRHAGE 77
383 PSYCHOTIC DISORDER 77
384 SPEECH DISORDER 77
385 SWOLLEN TONGUE 77
386 BRAIN FOG 76
387 LIMB DISCOMFORT 76
388 LIVER FUNCTION TEST INCREASED 76
389 ANKLE FRACTURE 75
390 NEPHRECTOMY 75
391 OBSESSIVE-COMPULSIVE DISORDER 75
392 PROCEDURAL PAIN 75
393 PULMONARY OEDEMA 75
394 SKIN DISORDER 75
395 TOTAL LUNG CAPACITY ABNORMAL 75
396 ACNE 74
397 BENIGN PROSTATIC HYPERPLASIA 74
398 DISORIENTATION 74
399 HAEMATOCHEZIA 74
400 NEOPLASM MALIGNANT 74
401 PAIN IN JAW 74
402 POLLAKIURIA 74
403 QUALITY OF LIFE DECREASED 74
404 RESTLESSNESS 74
405 EATING DISORDER 73
406 EMOTIONAL DISORDER 73
407 RESPIRATION ABNORMAL 73
408 SKIN BURNING SENSATION 73
409 SKIN HAEMORRHAGE 73
410 THINKING ABNORMAL 72
411 TREATMENT NONCOMPLIANCE 72
412 BRONCHIAL SECRETION RETENTION 71
413 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 71
414 DECREASED ACTIVITY 71
415 EYE DISORDER 71
416 FEAR 71
417 GLAUCOMA 71
418 UNDERDOSE 71
419 DECREASED IMMUNE RESPONSIVENESS 70
420 KIDNEY INFECTION 70
421 LEUKOPENIA 70
422 CARDIAC ARREST 69
423 COMPLETED SUICIDE 69
424 EYE INFECTION 69
425 IRRITABLE BOWEL SYNDROME 69
426 LYMPHADENOPATHY 69
427 PNEUMONIA BACTERIAL 69
428 HALLUCINATION, AUDITORY 68
429 NEUTROPHIL COUNT DECREASED 68
430 ORAL HERPES 68
431 PRE-EXISTING CONDITION IMPROVED 68
432 RIB FRACTURE 68
433 INTENTIONAL SELF-INJURY 67
434 THERAPEUTIC PRODUCT EFFECT DECREASED 67
435 AGEUSIA 66
436 CHEST X-RAY ABNORMAL 66
437 SYSTEMIC LUPUS ERYTHEMATOSUS 66
438 THERAPY CESSATION 66
439 ARRHYTHMIA 65
440 FEELING COLD 65
441 INFUSION SITE PRURITUS 65
442 MULTIPLE SCLEROSIS RELAPSE 65
443 PHARYNGEAL SWELLING 65
444 ALANINE AMINOTRANSFERASE INCREASED 64
445 ANOSMIA 64
446 DYSURIA 64
447 GAIT INABILITY 64
448 INJECTION SITE MASS 64
449 SCRATCH 63
450 ANGINA PECTORIS 62
451 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE 62
452 ASPARTATE AMINOTRANSFERASE INCREASED 62
453 MUSCULOSKELETAL CHEST PAIN 62
454 OROPHARYNGEAL DISCOMFORT 62
455 PRESYNCOPE 62
456 TOOTH ABSCESS 62
457 BLOOD GLUCOSE DECREASED 61
458 LOCALISED INFECTION 61
459 PHOTOSENSITIVITY REACTION 61
460 TIC 61
461 ASPIRATION 60
462 BLOOD PRESSURE ABNORMAL 60
463 COGNITIVE DISORDER 60
464 HEREDITARY ANGIOEDEMA 60
465 HYPOGLYCAEMIA 60
466 NEEDLE ISSUE 60
467 PSORIATIC ARTHROPATHY 60
468 RESPIRATORY DISTRESS 60
469 AORTIC VALVE STENOSIS 59
470 DYSKINESIA 59
471 GASTRITIS 59
472 MAST CELL ACTIVATION SYNDROME 59
473 SOMNAMBULISM 59
474 TRANSAMINASES INCREASED 59
475 WEIGHT FLUCTUATION 59
476 BLOOD CALCIUM INCREASED 58
477 BRONCHIAL WALL THICKENING 58
478 CARDIOMYOPATHY 58
479 DYSSTASIA 58
480 HYPOKALAEMIA 58
481 INTERSTITIAL LUNG DISEASE 58
482 TOOTH INFECTION 58
483 ANAPHYLACTIC SHOCK 57
484 ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME 57
485 CARDIAC MURMUR 57
486 HAEMATOMA 57
487 HEPATIC STEATOSIS 57
488 MUSCULOSKELETAL PAIN 57
489 PULMONARY HYPERTENSION 57
490 WITHDRAWAL SYNDROME 57
491 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 56
492 FLANK PAIN 56
493 PRODUCT DISTRIBUTION ISSUE 56
494 RIGHT ATRIAL HYPERTROPHY 56
495 RIGHT VENTRICULAR HYPERTROPHY 56
496 SKIN INFECTION 56
497 BLOOD PRESSURE FLUCTUATION 55
498 BRADYCARDIA 55
499 FOOT FRACTURE 55
500 PRODUCT ADMINISTRATION ERROR 55
501 PROLONGED EXPIRATION 55
502 PULMONARY THROMBOSIS 55
503 SKIN IRRITATION 55
504 ACUTE RESPIRATORY FAILURE 54
505 CYSTIC FIBROSIS 54
506 INTERVERTEBRAL DISC PROTRUSION 54
507 MUSCLE TWITCHING 54
508 RESTLESS LEGS SYNDROME 54
509 LIGAMENT SPRAIN 53
510 LIVER DISORDER 53
511 MOUTH HAEMORRHAGE 53
512 PULMONARY FUNCTION TEST DECREASED 53
513 RESPIRATORY RATE INCREASED 53
514 CAPILLARITIS 52
515 DRUG-INDUCED LIVER INJURY 52
516 DYSPNOEA AT REST 52
517 HEART RATE IRREGULAR 52
518 LUNG OPACITY 52
519 ORAL PAIN 52
520 URINARY RETENTION 52
521 EAR DISCOMFORT 51
522 END STAGE RENAL DISEASE 51
523 FACIAL PAIN 51
524 KNEE ARTHROPLASTY 51
525 NEPHROPATHY 51
526 PHARYNGITIS STREPTOCOCCAL 51
527 SCIATICA 51
528 APPETITE DISORDER 50
529 BACK DISORDER 50
530 FULL BLOOD COUNT DECREASED 50
531 HALLUCINATION, VISUAL 50
532 INFUSION SITE BRUISING 50
533 PRODUCT AVAILABILITY ISSUE 50
534 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 50
535 TEMPERATURE INTOLERANCE 50
536 THIRST 50
537 TOTAL LUNG CAPACITY DECREASED 50
538 BREAST CANCER 49
539 CONCUSSION 49
540 DRUG EFFECT LESS THAN EXPECTED 49
541 DYSARTHRIA 49
542 LARYNGITIS 49
543 PERIPHERAL COLDNESS 49
544 RED BLOOD CELL COUNT DECREASED 49
545 ROTATOR CUFF SYNDROME 49
546 TOOTH DISORDER 49
547 CROHN^S DISEASE 48
548 EYE DISCHARGE 48
549 FEEDING DISORDER 48
550 HEAD DISCOMFORT 48
551 HIP FRACTURE 48
552 MOVEMENT DISORDER 48
553 PLASMA CELL MYELOMA 48
554 PNEUMONIA ASPIRATION 48
555 PNEUMONITIS 48
556 TASTE DISORDER 48
557 TOXICITY TO VARIOUS AGENTS 48
558 URINARY INCONTINENCE 48
559 BACK INJURY 47
560 DRUG DEPENDENCE 47
561 HYSTERECTOMY 47
562 INITIAL INSOMNIA 47
563 INTESTINAL OBSTRUCTION 47
564 IRON DEFICIENCY ANAEMIA 47
565 MUSCULOSKELETAL DISCOMFORT 47
566 PERSONALITY CHANGE 47
567 PHARYNGITIS 47
568 UPPER LIMB FRACTURE 47
569 CHROMATURIA 46
570 DIPLOPIA 46
571 EXTRA DOSE ADMINISTERED 46
572 GASTRIC DISORDER 46
573 HYPERCHOLESTEROLAEMIA 46
574 POST PROCEDURAL COMPLICATION 46
575 SENSORY DISTURBANCE 46
576 SKIN LACERATION 46
577 SPINAL OPERATION 46
578 THERAPY PARTIAL RESPONDER 46
579 BLOOD SODIUM DECREASED 45
580 BODY TEMPERATURE DECREASED 45
581 FEELING JITTERY 45
582 IMPAIRED GASTRIC EMPTYING 45
583 ORAL CANDIDIASIS 45
584 RESPIRATORY SYNCYTIAL VIRUS TEST POSITIVE 45
585 BLOOD IRON DECREASED 44
586 DERMATITIS ALLERGIC 44
587 HUMAN RHINOVIRUS TEST POSITIVE 44
588 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 44
589 ISCHAEMIC CARDIOMYOPATHY 44
590 MULTIPLE SCLEROSIS 44
591 PULMONARY CONGESTION 44
592 BRONCHIAL HYPERREACTIVITY 43
593 COLITIS 43
594 DEVICE MALFUNCTION 43
595 ELECTROCARDIOGRAM QT PROLONGED 43
596 IMMUNE SYSTEM DISORDER 43
597 PLEURITIC PAIN 43
598 PRODUCT USE COMPLAINT 43
599 SCAR 43
600 SKIN SWELLING 43
601 BIPOLAR DISORDER 42
602 DEPRESSIVE SYMPTOM 42
603 HEPATIC FUNCTION ABNORMAL 42
604 LIVER FUNCTION TEST ABNORMAL 42
605 LUNG NEOPLASM MALIGNANT 42
606 NASAL DISCHARGE DISCOLOURATION 42
607 SPUTUM PURULENT 42
608 APHASIA 41
609 MUSCLE TIGHTNESS 41
610 POOR VENOUS ACCESS 41
611 SKIN PLAQUE 41
612 TOOTHACHE 41
613 WOUND 41
614 AFFECTIVE DISORDER 40
615 ATTENTION DEFICIT HYPERACTIVITY DISORDER 40
616 DIZZINESS POSTURAL 40
617 HERNIA 40
618 LUNG INFECTION 40
619 PERICARDIAL EFFUSION 40
620 SPINAL FRACTURE 40
621 SPUTUM INCREASED 40
622 TENDERNESS 40
623 TONGUE BITING 40
624 VITAMIN D DEFICIENCY 40
625 WRIST FRACTURE 40
626 ALLERGIC GRANULOMATOUS ANGIITIS 39
627 CHRONIC SPONTANEOUS URTICARIA 39
628 DERMATITIS 39
629 GASTROENTERITIS 39
630 HORDEOLUM 39
631 LABORATORY TEST ABNORMAL 39
632 POST-TRAUMATIC STRESS DISORDER 39
633 PRODUCT PRESCRIBING ISSUE 39
634 SKIN ULCER 39
635 CLOSTRIDIUM DIFFICILE INFECTION 38
636 COVID-19 PNEUMONIA 38
637 DEAFNESS 38
638 DRUG ABUSE 38
639 EYELID PAIN 38
640 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 38
641 PANCYTOPENIA 38
642 PRODUCT STORAGE ERROR 38
643 SARS-COV-2 TEST POSITIVE 38
644 SINUS TACHYCARDIA 38
645 SOCIAL AVOIDANT BEHAVIOUR 38
646 SWELLING OF EYELID 38
647 TRICUSPID VALVE INCOMPETENCE 38
648 ARTHROPOD BITE 37
649 COMA 37
650 FOETAL EXPOSURE DURING PREGNANCY 37
651 HYPERKALAEMIA 37
652 IMPAIRED WORK ABILITY 37
653 MENTAL STATUS CHANGES 37
654 RECTAL HAEMORRHAGE 37
655 ACCIDENT 36
656 AUTOIMMUNE DISORDER 36
657 CARDIOMEGALY 36
658 CHOLECYSTECTOMY 36
659 DEVICE LEAKAGE 36
660 DRUG EFFECT DECREASED 36
661 DRY THROAT 36
662 GLOSSODYNIA 36
663 HYPERLIPIDAEMIA 36
664 IMPAIRED HEALING 36
665 LACTIC ACIDOSIS 36
666 NERVE COMPRESSION 36
667 PNEUMONIA HAEMOPHILUS 36
668 PRODUCT PREPARATION ERROR 36
669 VOCAL CORD DYSFUNCTION 36
670 WOUND INFECTION 36
671 BEHAVIOUR DISORDER 35
672 DEMENTIA 35
673 DISABILITY 35
674 DIVERTICULUM 35
675 FAECES DISCOLOURED 35
676 INCREASED APPETITE 35
677 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 35
678 JOINT STIFFNESS 35
679 LOWER LIMB FRACTURE 35
680 OSTEOPENIA 35
681 PARAESTHESIA ORAL 35
682 PNEUMONIA VIRAL 35
683 PNEUMOTHORAX 35
684 SELF-INJURIOUS IDEATION 35
685 VITAL CAPACITY DECREASED 35
686 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 35
687 BODY TEMPERATURE INCREASED 34
688 C-REACTIVE PROTEIN INCREASED 34
689 CYANOSIS 34
690 GESTATIONAL DIABETES 34
691 JOINT DISLOCATION 34
692 NOCTURIA 34
693 PALLOR 34
694 SENSITIVE SKIN 34
695 ADRENAL INSUFFICIENCY 33
696 BODY HEIGHT DECREASED 33
697 CHOKING SENSATION 33
698 COLD SWEAT 33
699 DEVICE DISLOCATION 33
700 DEVICE USE ISSUE 33
701 EPILEPSY 33
702 FREQUENT BOWEL MOVEMENTS 33
703 GALLBLADDER DISORDER 33
704 INJECTION SITE IRRITATION 33
705 SCREAMING 33
706 SINUS HEADACHE 33
707 TENDONITIS 33
708 ADJUSTMENT DISORDER 32
709 ENURESIS 32
710 HEART SOUNDS 32
711 HYPOCALCAEMIA 32
712 MAJOR DEPRESSION 32
713 SKIN CANCER 32
714 THYROID DISORDER 32
715 ULCER 32
716 CONVULSION 31
717 FOREIGN BODY SENSATION IN EYES 31
718 HYPERVENTILATION 31
719 INCREASED BRONCHIAL SECRETION 31
720 INTENTIONAL OVERDOSE 31
721 INTERNAL HAEMORRHAGE 31
722 LARYNGEAL STENOSIS 31
723 NERVOUS SYSTEM DISORDER 31
724 PAIN OF SKIN 31
725 PETECHIAE 31
726 PSEUDOMONAS INFECTION 31
727 RASH PAPULAR 31
728 RHONCHI 31
729 SEPTIC SHOCK 31
730 SKIN ABRASION 31
731 SYMPTOM RECURRENCE 31
732 APATHY 30
733 BLINDNESS 30
734 CEREBRAL HAEMORRHAGE 30
735 DEVICE INFUSION ISSUE 30
736 DRUG ERUPTION 30
737 EOSINOPHIL COUNT ABNORMAL 30
738 HAEMOGLOBIN INCREASED 30
739 INCORRECT PRODUCT ADMINISTRATION DURATION 30
740 INCREASED TENDENCY TO BRUISE 30
741 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 30
742 MENTAL IMPAIRMENT 30
743 NEUROPSYCHIATRIC SYMPTOMS 30
744 PARANASAL SINUS DISCOMFORT 30
745 PERIORBITAL SWELLING 30
746 VIRAL TEST POSITIVE 30
747 AFFECT LABILITY 29
748 ALLERGIC SINUSITIS 29
749 ANHEDONIA 29
750 BLOOD CREATINE PHOSPHOKINASE INCREASED 29
751 BLOOD POTASSIUM INCREASED 29
752 CARDIO-RESPIRATORY ARREST 29
753 DEPRESSED LEVEL OF CONSCIOUSNESS 29
754 DEVICE BREAKAGE 29
755 FEBRILE NEUTROPENIA 29
756 GLUCOSE TOLERANCE IMPAIRED 29
757 HAEMATOCRIT DECREASED 29
758 HEPATITIS 29
759 INTERNATIONAL NORMALISED RATIO INCREASED 29
760 MICTURITION URGENCY 29
761 SINUS OPERATION 29
762 BRONCHIAL OBSTRUCTION 28
763 BRONCHIOLITIS 28
764 CORONARY ARTERY DISEASE 28
765 HAEMATURIA 28
766 HYPOGAMMAGLOBULINAEMIA 28
767 INFUSION SITE WARMTH 28
768 MACULAR DEGENERATION 28
769 MALIGNANT NEOPLASM PROGRESSION 28
770 MOUTH ULCERATION 28
771 MUSCLE STRAIN 28
772 PAPULE 28
773 POST PROCEDURAL INFECTION 28
774 PRODUCT PRESCRIBING ERROR 28
775 PRURITUS GENERALISED 28
776 RENAL INJURY 28
777 RESPIRATORY DEPRESSION 28
778 RHABDOMYOLYSIS 28
779 SCAB 28
780 SENSITIVITY TO WEATHER CHANGE 28
781 VITAMIN D DECREASED 28
782 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 27
783 CONCOMITANT DISEASE AGGRAVATED 27
784 DRUG WITHDRAWAL SYNDROME 27
785 EMBOLISM VENOUS 27
786 ERUCTATION 27
787 FEMALE GENITAL TRACT FISTULA 27
788 FEMUR FRACTURE 27
789 GASTROINTESTINAL INFECTION 27
790 GLYCOSYLATED HAEMOGLOBIN INCREASED 27
791 HIP ARTHROPLASTY 27
792 HUNGER 27
793 INFUSION SITE MASS 27
794 NEUROPSYCHOLOGICAL SYMPTOMS 27
795 OSTEONECROSIS 27
796 SINUSITIS FUNGAL 27
797 SUPRAVENTRICULAR TACHYCARDIA 27
798 ALLERGY TO ANIMAL 26
799 ASTHMA EXERCISE INDUCED 26
800 BLOOD BILIRUBIN INCREASED 26
801 BLOOD MAGNESIUM DECREASED 26
802 COLITIS ULCERATIVE 26
803 COORDINATION ABNORMAL 26
804 CUSHINGOID 26
805 DYSPHEMIA 26
806 ECONOMIC PROBLEM 26
807 EOSINOPHILIC PNEUMONIA 26
808 EXERCISE TOLERANCE DECREASED 26
809 HYPOPHAGIA 26
810 INFUSION SITE EXTRAVASATION 26
811 INJECTION SITE DISCOLOURATION 26
812 MANIA 26
813 PARANASAL SINUS HYPERSECRETION 26
814 PHARYNGEAL OEDEMA 26
815 PRODUCT TASTE ABNORMAL 26
816 RASH GENERALISED 26
817 SARCOIDOSIS 26
818 SEDATION 26
819 SHOCK 26
820 SQUAMOUS CELL CARCINOMA OF SKIN 26
821 BLADDER DISORDER 25
822 COMPLICATION ASSOCIATED WITH DEVICE 25
823 CYST 25
824 DRUG EFFECT INCOMPLETE 25
825 EYE INFLAMMATION 25
826 GINGIVAL PAIN 25
827 HAEMORRHOIDS 25
828 KNEE OPERATION 25
829 NAIL DISORDER 25
830 OESOPHAGITIS 25
831 PLATELET COUNT INCREASED 25
832 SLUGGISHNESS 25
833 SPINAL DISORDER 25
834 SUICIDAL BEHAVIOUR 25
835 VAGINAL HAEMORRHAGE 25
836 VASCULAR DEVICE INFECTION 25
837 ACTIVITIES OF DAILY LIVING IMPAIRED 24
838 ASCITES 24
839 BRONCHIAL DISORDER 24
840 DECUBITUS ULCER 24
841 DEPRESSION SUICIDAL 24
842 DEVICE USE ERROR 24
843 EYE HAEMORRHAGE 24
844 HAEMATEMESIS 24
845 HYPERVOLAEMIA 24
846 HYPOAESTHESIA ORAL 24
847 MELAENA 24
848 NASAL DISCOMFORT 24
849 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 24
850 PREMATURE DELIVERY 24
851 RESPIRATORY TRACT INFECTION VIRAL 24
852 SALIVARY HYPERSECRETION 24
853 SHOULDER OPERATION 24
854 SNORING 24
855 TOOTH EXTRACTION 24
856 ACTINIC KERATOSIS 23
857 ASPHYXIA 23
858 DEVICE DIFFICULT TO USE 23
859 DEVICE OCCLUSION 23
860 ENCEPHALOPATHY 23
861 FORMICATION 23
862 FRUSTRATION TOLERANCE DECREASED 23
863 GASTRIC ULCER 23
864 INFUSION SITE REACTION 23
865 LEUKOCYTOSIS 23
866 METABOLIC ACIDOSIS 23
867 MUSCLE DISORDER 23
868 PAROSMIA 23
869 PRECANCEROUS CONDITION 23
870 REBOUND EFFECT 23
871 SKIN ATROPHY 23
872 SKIN WEEPING 23
873 SOLAR LENTIGO 23
874 TUBULOINTERSTITIAL NEPHRITIS 23
875 ADVERSE REACTION 22
876 BLOOD LACTIC ACID INCREASED 22
877 DECREASED INTEREST 22
878 DENTAL CARIES 22
879 EAR PRURITUS 22
880 ERYTHEMA OF EYELID 22
881 EXTRAPYRAMIDAL DISORDER 22
882 FACE OEDEMA 22
883 FOLLICULITIS 22
884 GINGIVAL BLEEDING 22
885 HAND FRACTURE 22
886 IMMUNOSUPPRESSION 22
887 INFUSION SITE INDURATION 22
888 INFUSION SITE INFECTION 22
889 JOINT RANGE OF MOTION DECREASED 22
890 LEFT VENTRICULAR HYPERTROPHY 22
891 MYASTHENIA GRAVIS 22
892 NEOPLASM PROGRESSION 22
893 PANCREATITIS ACUTE 22
894 PULMONARY ARTERIAL HYPERTENSION 22
895 PULMONARY PAIN 22
896 RENAL FAILURE ACUTE 22
897 SENSATION OF FOREIGN BODY 22
898 SPINAL STENOSIS 22
899 TEARFULNESS 22
900 THROAT CLEARING 22
901 VITREOUS FLOATERS 22
902 ABNORMAL WEIGHT GAIN 21
903 ATELECTASIS 21
904 BLOOD URINE PRESENT 21
905 BONE DENSITY DECREASED 21
906 DEVICE RELATED INFECTION 21
907 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 21
908 EAR DISORDER 21
909 GENERALISED OEDEMA 21
910 GENERALISED TONIC-CLONIC SEIZURE 21
911 HEPATIC CIRRHOSIS 21
912 HEPATOMEGALY 21
913 HEPATOTOXICITY 21
914 HOSTILITY 21
915 INFUSION SITE IRRITATION 21
916 JAUNDICE 21
917 MYOPATHY 21
918 ORTHOSTATIC HYPOTENSION 21
919 OSTEOMYELITIS 21
920 PERIORBITAL OEDEMA 21
921 PERIORBITAL PAIN 21
922 PHOTODERMATOSIS 21
923 POLYP 21
924 PRODUCT DISPENSING ERROR 21
925 RESTRICTIVE PULMONARY DISEASE 21
926 SALPINGO-OOPHORECTOMY UNILATERAL 21
927 TENDON RUPTURE 21
928 VENTRICULAR TACHYCARDIA 21
929 ABORTION SPONTANEOUS 20
930 BLOOD GLUCOSE ABNORMAL 20
931 BLOOD LACTATE DEHYDROGENASE INCREASED 20
932 BODY TEMPERATURE ABNORMAL 20
933 BONE DISORDER 20
934 BOWEL MOVEMENT IRREGULARITY 20
935 CATAPLEXY 20
936 DEVICE FAILURE 20
937 DISSOCIATION 20
938 DRUG DOSE OMISSION BY DEVICE 20
939 DRUG TOLERANCE DECREASED 20
940 DYSPLASTIC NAEVUS 20
941 ERECTILE DYSFUNCTION 20
942 GRANULOMA 20
943 GRIP STRENGTH DECREASED 20
944 HEPATIC FAILURE 20
945 IMPAIRED DRIVING ABILITY 20
946 INCORRECT DRUG ADMINISTRATION RATE 20
947 INFUSION SITE RASH 20
948 LIGAMENT RUPTURE 20
949 MALIGNANT MELANOMA 20
950 MULTIPLE ORGAN DYSFUNCTION SYNDROME 20
951 MUSCULOSKELETAL DISORDER 20
952 NEPHROGENIC ANAEMIA 20
953 OBSESSIVE-COMPULSIVE SYMPTOM 20
954 ORAL DISCOMFORT 20
955 PARALYSIS 20
956 PURPURA 20
957 RHINITIS PERENNIAL 20
958 ROSACEA 20
959 SCHIZOPHRENIA 20
960 SJOGREN^S SYNDROME 20
961 SPINAL OSTEOARTHRITIS 20
962 VISUAL ACUITY REDUCED 20
963 VITAMIN B12 DEFICIENCY 20
964 ABNORMAL LOSS OF WEIGHT 19
965 BLEPHARITIS 19
966 DEREALISATION 19
967 FACTOR V LEIDEN MUTATION 19
968 GASTROINTESTINAL PAIN 19
969 GLOMERULAR FILTRATION RATE DECREASED 19
970 HOSPICE CARE 19
971 INJECTION SITE DISCHARGE 19
972 INJECTION SITE VESICLES 19
973 INJECTION SITE WARMTH 19
974 LUNG INFILTRATION 19
975 LYMPHOEDEMA 19
976 MULTIPLE FRACTURES 19
977 NASAL DRYNESS 19
978 NASAL TURBINATE HYPERTROPHY 19
979 NEGATIVE THOUGHTS 19
980 NERVE INJURY 19
981 PO2 DECREASED 19
982 PRODUCT PHYSICAL ISSUE 19
983 PROSTATE CANCER 19
984 RAYNAUD^S PHENOMENON 19
985 RESPIRATORY ARREST 19
986 REVERSIBLE AIRWAYS OBSTRUCTION 19
987 SKIN MASS 19
988 SKIN REACTION 19
989 TERMINAL INSOMNIA 19
990 VIRAL UPPER RESPIRATORY TRACT INFECTION 19
991 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 18
992 ATRIAL FLUTTER 18
993 BLINDNESS UNILATERAL 18
994 BLOOD ALKALINE PHOSPHATASE INCREASED 18
995 BRUXISM 18
996 COAGULOPATHY 18
997 COMPRESSION FRACTURE 18
998 DIAPHRAGMATIC DISORDER 18
999 EXPIRED PRODUCT ADMINISTERED 18